Fettvävnadsförstoring

Fettvävnadsförstoring, also known as lipohypertrophy or lipodystrophy, is a condition characterized by the abnormal accumulation of fat tissue. This can manifest in various ways, affecting either localized areas of the body or presenting as a more generalized condition. The exact causes are not always fully understood, but it can be associated with genetic factors, hormonal imbalances, certain medical conditions, or as a side effect of specific medications, such as insulin injections used for diabetes management.

In localized forms, fettvävnadsförstoring might appear as lumps or thickened areas of subcutaneous fat. Generalized forms can lead to significant disfigurement and metabolic complications. The appearance of the affected areas can vary, ranging from smooth, soft swellings to more firm and uneven tissue.

Diagnosis typically involves a physical examination and may be supported by imaging techniques like ultrasound or MRI to assess the extent and nature of the fat accumulation. Treatment strategies are varied and depend on the underlying cause and the severity of the condition. For localized lipohypertrophy related to injections, altering injection sites is crucial. In cases associated with metabolic issues, managing the underlying condition and lifestyle modifications such as diet and exercise are important. In some instances, surgical intervention may be considered for cosmetic or functional reasons.